Market Snapshot

S&P Futures
Dow Futures
NASDAQ Futures

2.83$0.11 4.04%
Market open       15:49:26 pm   

Stock Snapshot

2.72
Prev. Close
2.71
Open
635.11M
Market Cap
21.07M
Number of Shares
2.6750
Day Low
2.8300
Day High
2.83
9.40
P/E Ratio
193.98M
Free Float in %
0.30
EPS 2021
-2.64
Book Value per Share
6.89
Cash Flow per Share
Endo International plc (ENDP)
Endo International plc (ENDP) stock rallied over 4.04% intraday to trade at $2.83 share on NASDAQ. The stock opened with a fall of % at $2.71 and touched an intraday high of $2.8300, rising 4.04% against the last close of $2.72. The stock went to a low of $2.6750 during the session.

Historical Data

DateOpenCloseDaily HighDaily LowVolume
2021-09-10$2.54$2.79$3.33$2.51119,522,365
2021-09-03$2.13$2.15$2.21$2.041,528,090,000
2021-09-02$2.13$2.14$2.29$2.091,420,880,000
2021-09-01$2.28$2.10$2.31$2.061,628,530,000
2021-08-31$1.98$2.29$2.36$1.942,161,720,000
2021-08-30$2.35$2.30$2.41$2.29618,850,000
2021-08-27$2.40$2.32$2.42$2.29733,070,000
2021-08-26$2.54$2.40$2.55$2.36683,080,000
2021-08-25$2.62$2.53$2.63$2.49773,510,000
2021-08-24$2.64$2.64$2.72$2.411,109,300,000
2021-08-23$2.26$2.68$2.72$2.203,373,830,000
Endo International plc
Minerva House
First Floor Simmonscourt Road Ballsbridge
Dublin 4
Ireland

http://www.endo.com
353 1 268 2000
Employees
3397
Sector
Healthcare
Sales or Revenue
2.83B
Industry
Drug Manufacturers - Specialty & Generic
5Y Sales Change
-2.30
Fiscal Year Ends
2020-12-30

Endo International plc
Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; AVEED to treat hypogonadism; PERCOCET to treat moderate-to-moderately-severe pain; TESTOPEL an implantable pellet indicated for TRT in conditions associated with a deficiency or absence of endogenous testosterone; EDEX to treat erectile dysfunction; LIDODERM a topical patch product containing lidocaine for the relief of pain; and products for the pain management and urology. The company's Sterile Injectables segment manufactures VASOSTRICT, a vasopressin injection; ADRENALIN, a non-selective adrenergic agonist; and APLISOL, which is a sterile aqueous solution, as well as generic sterile injectable products, including ertapenem for injections and ephedrine sulfate injections. Its Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic products, and sprays. The company's International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women's health, oncology, and transplantation. The company sells its branded pharmaceuticals and generics to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam